Lexaria Bioscience (LEXX) traded up 3.01 % during a 24 hours period ending at 11:03 PM Central Europe on Monday 26th. One Lexaria Bioscience stock can currently be bought for about USD 2.92 on popular exchanges. Current supply of Lexaria Bioscience stocks is 1.7 mn. Lexaria Bioscience has a current market capitalization of USD 5.1 mn and approximately USD 71.5 k worth of Lexaria Bioscience was traded on exchanges in the last 24 hours. Since last month end, Lexaria Bioscience has traded -8.61 % down. Simple moving average of last 200 days is at USD 9.16. The highest price of past 52 weeks was recorded at USD 21.6 on 12/12/2025. 52 weeks low was at USD 2.43 on 10/19/2026.

Here is how related stocks have performed in the past 24 hours:

  • Dynasty Gold (DYG.V) traded flat 0 % and now trades at CAD 0.12. Current market capitalisation for Dynasty Gold is CAD 8.5 mn.

  • Canadian Critical Minerals I (CCMI.V) traded flat 0 % and now trades at CAD 0.02. Current market capitalisation for Canadian Critical Minerals I is CAD 8.4 mn.

  • Destiny Media (DSY.V) traded flat 0 % and now trades at CAD 0.88. Destiny Media has a market capitalisation of CAD 8.5 mn.

  • Grizzly Discoveries (GZD.V) traded flat 0 % and now trades at CAD 0.04. Grizzly Discoveries has a market capitalisation of CAD 8.4 mn.

  • Blast (BLST.CN) traded up 5.56 % and now trades at CAD 0.28. Current market capitalisation for Blast is CAD 8.5 mn. Blast Resources Inc. is advancing its exploration activities in the Athabasca Basin, focusing on its Wales‑Lake project. The company has identified a nine‑kilometre structural corridor, supported by airborne magnetic surveys and historical data, which could guide further drilling. Although the corridor’s potential for uranium mineralisation remains unconfirmed, it represents a concrete target for upcoming exploration efforts. The firm is also working to refine its objectives, secure funding, and deliver measurable results to validate the area’s resource prospects. As the broader uranium market evolves, Blast Resources positions itself to contribute to future supply through early-stage exploration, while acknowledging the inherent geological and financial uncertainties that accompany such ventures.

About Lexaria Bioscience

Lexaria Bioscience Corp is a health care company operating in the pharmaceutical industry. The company is located in Kelowna, Canada, and Improves the efficiency of how active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods. Their technology can be applied to various ingestible product formats such as foods, beverages, oral suspensions, tablets, and capsules. Operating a licensed in-house research laboratory, Lexaria holds a substantial intellectual property portfolio. You can find more information about the company and their offerings on their website, www.lexariabioscience.com , and they are listed on the Nasdaq stock exchange.